Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.

CK Appel; S Gallego-Pedersen; L Andersen; S Blancheflor Kristensen; Ming Ding; S Falk; M Sayilekshmy; C Gabel-Jensen; AM Heegaard

doi:10.1038/s41598-019-43721-6

Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.

CK Appel, S Gallego-Pedersen, L Andersen, S Blancheflor Kristensen, Ming Ding, S Falk, M Sayilekshmy, C Gabel-Jensen, AM Heegaard

KI, OUH, Research unit of orthopaedic surgery (Odense)

Research output: Contribution to journal › Comment/debate › Research › peer-review

76 Downloads (Pure)

Abstract

The Acknowledgements section in this Article is incomplete. “The authors thank Camilla Skånstrøm Dall and Tina Maria Estrup Axen for technical assistance. This project was supported by Advokat Bent Thorbergs Fond.” should read: “The authors thank Camilla Skånstrøm Dall and Tina Maria Estrup Axen for technical assistance. This project was supported by Advokat Bent Thorbergs Fond. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 642720.”

Original language	English
Article number	7399
Journal	Scientific Reports
Volume	9
Number of pages	1
ISSN	2045-2322
DOIs	https://doi.org/10.1038/s41598-019-43721-6
Publication status	Published - 9. May 2019

Documents & Links

10.1038/s41598-019-43721-6Licence: CC BY

Author Correction- The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.Final published version, 653 KBLicence: CC BY

Cite this

Appel, CK., Gallego-Pedersen, S., Andersen, L., Blancheflor Kristensen, S., Ding, M., Falk, S., Sayilekshmy, M., Gabel-Jensen, C., & Heegaard, AM. (2019). Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain. Scientific Reports, 9, Article 7399. https://doi.org/10.1038/s41598-019-43721-6

@article{d82f61660d3e453db95946c0708eb9cf,

title = "Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.",

abstract = "The Acknowledgements section in this Article is incomplete. “The authors thank Camilla Sk{\aa}nstr{\o}m Dall and Tina Maria Estrup Axen for technical assistance. This project was supported by Advokat Bent Thorbergs Fond.” should read: “The authors thank Camilla Sk{\aa}nstr{\o}m Dall and Tina Maria Estrup Axen for technical assistance. This project was supported by Advokat Bent Thorbergs Fond. This project has received funding from the European Union{\textquoteright}s Horizon 2020 research and innovation programme under the Marie Sk{\l}odowska-Curie grant agreement No 642720.”",

author = "CK Appel and S Gallego-Pedersen and L Andersen and {Blancheflor Kristensen}, S and Ming Ding and S Falk and M Sayilekshmy and C Gabel-Jensen and AM Heegaard",

year = "2019",

month = may,

day = "9",

doi = "10.1038/s41598-019-43721-6",

language = "English",

volume = "9",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

}

Appel, CK, Gallego-Pedersen, S, Andersen, L, Blancheflor Kristensen, S, Ding, M, Falk, S, Sayilekshmy, M, Gabel-Jensen, C & Heegaard, AM 2019, 'Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.', Scientific Reports, vol. 9, 7399. https://doi.org/10.1038/s41598-019-43721-6

TY - JOUR

T1 - Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.

AU - Appel, CK

AU - Gallego-Pedersen, S

AU - Andersen, L

AU - Blancheflor Kristensen, S

AU - Ding, Ming

AU - Falk, S

AU - Sayilekshmy, M

AU - Gabel-Jensen, C

AU - Heegaard, AM

PY - 2019/5/9

Y1 - 2019/5/9

N2 - The Acknowledgements section in this Article is incomplete. “The authors thank Camilla Skånstrøm Dall and Tina Maria Estrup Axen for technical assistance. This project was supported by Advokat Bent Thorbergs Fond.” should read: “The authors thank Camilla Skånstrøm Dall and Tina Maria Estrup Axen for technical assistance. This project was supported by Advokat Bent Thorbergs Fond. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 642720.”

AB - The Acknowledgements section in this Article is incomplete. “The authors thank Camilla Skånstrøm Dall and Tina Maria Estrup Axen for technical assistance. This project was supported by Advokat Bent Thorbergs Fond.” should read: “The authors thank Camilla Skånstrøm Dall and Tina Maria Estrup Axen for technical assistance. This project was supported by Advokat Bent Thorbergs Fond. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 642720.”

U2 - 10.1038/s41598-019-43721-6

DO - 10.1038/s41598-019-43721-6

M3 - Comment/debate

C2 - 31068648

SN - 2045-2322

VL - 9

JO - Scientific Reports

JF - Scientific Reports

M1 - 7399

ER -

Author Correction: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain.

Abstract

Documents & Links

Fingerprint

Cite this